{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T12:58:02Z","timestamp":1789995482974,"version":"4.0.1"},"reference-count":113,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,5,11]],"date-time":"2025-05-11T00:00:00Z","timestamp":1746921600000},"content-version":"am","delay-in-days":314,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01AR079489"],"award-info":[{"award-number":["R01AR079489"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01 AR081264"],"award-info":[{"award-number":["R01 AR081264"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical Pharmacology"],"published-print":{"date-parts":[[2024,7]]},"DOI":"10.1016\/j.bcp.2024.116273","type":"journal-article","created":{"date-parts":[[2024,5,8]],"date-time":"2024-05-08T11:15:47Z","timestamp":1715166947000},"page":"116273","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"special_numbering":"C","title":["Relaxin as a treatment for musculoskeletal fibrosis: What we know and future directions"],"prefix":"10.1016","volume":"225","author":[{"given":"Atousa","family":"Nourmahnad","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad","family":"Javad Shariyate","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad","family":"Khak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark W.","family":"Grinstaff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3992-3489","authenticated-orcid":false,"given":"Ara","family":"Nazarian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edward K.","family":"Rodriguez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"12","key":"10.1016\/j.bcp.2024.116273_b0005","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1038\/s41584-019-0322-7","article-title":"Shared and distinct mechanisms of fibrosis","volume":"15","author":"Distler","year":"2019","journal-title":"Nat. Rev. Rheumatol."},{"issue":"3","key":"10.1016\/j.bcp.2024.116273_b0010","doi-asserted-by":"crossref","first-page":"196","DOI":"10.2174\/1566524021666210309113650","article-title":"Human recombinant relaxin (serelaxin) as anti-fibrotic agent: Pharmacology, limitations and actual perspectives","volume":"22","author":"Sassoli","year":"2022","journal-title":"Curr. Mol. Med."},{"issue":"7835","key":"10.1016\/j.bcp.2024.116273_b0015","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1038\/s41586-020-2938-9","article-title":"Fibrosis: from mechanisms to medicines","volume":"587","author":"Henderson","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.bcp.2024.116273_b0020","doi-asserted-by":"crossref","first-page":"1985","DOI":"10.1007\/s00432-015-1974-6","article-title":"Radiation-induced fibrosis: mechanisms and implications for therapy","volume":"141","author":"Straub","year":"2015","journal-title":"J. Cancer Res. Clin. Oncol."},{"issue":"7","key":"10.1016\/j.bcp.2024.116273_b0025","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1016\/j.bbadis.2013.02.007","volume":"1832","author":"Wells","year":"2013","journal-title":"Tissue Mechanics and Fibrosis. Biochimica Et Biophysica Acta (BBA)-Molecular Basis of Disease"},{"issue":"11","key":"10.1016\/j.bcp.2024.116273_b0030","doi-asserted-by":"crossref","first-page":"3343","DOI":"10.1016\/j.arth.2020.05.070","article-title":"Human fibrosis: is there evidence for a genetic predisposition in musculoskeletal tissues?","volume":"35","author":"Dagneaux","year":"2020","journal-title":"J. Arthroplasty"},{"issue":"3","key":"10.1016\/j.bcp.2024.116273_b0035","doi-asserted-by":"crossref","first-page":"81S","DOI":"10.1378\/chest.99.3_Supplement.81S","article-title":"Fibroproliferative disorders","volume":"99","author":"Bitterman","year":"1991","journal-title":"Chest"},{"issue":"2","key":"10.1016\/j.bcp.2024.116273_b0040","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/j.knee.2019.01.010","article-title":"Regulation of MMP and TIMP expression in synovial fibroblasts from knee osteoarthritis with flexion contracture using adenovirus-mediated relaxin gene therapy","volume":"26","author":"Ko","year":"2019","journal-title":"Knee"},{"key":"10.1016\/j.bcp.2024.116273_b0045","doi-asserted-by":"crossref","unstructured":"Blessing, W.A., et al., Intraarticular injection of relaxin-2 alleviates shoulder arthrofibrosis. Proceedings of the National Academy of Sciences, 201116(25): p. 12183-12192.","DOI":"10.1073\/pnas.1900355116"},{"issue":"2","key":"10.1016\/j.bcp.2024.116273_b0050","doi-asserted-by":"crossref","first-page":"415","DOI":"10.3349\/ymj.2017.58.2.415","article-title":"Relaxin modulates the expression of MMPs and TIMPs in fibroblasts of patients with carpal tunnel syndrome","volume":"58","author":"Kang","year":"2017","journal-title":"Yonsei Med. J."},{"key":"10.1016\/j.bcp.2024.116273_b0055","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1007\/s12016-008-8114-x","article-title":"Recent advances in the treatment of systemic sclerosis","volume":"36","author":"Bournia","year":"2009","journal-title":"Clin Rev Allergy Immunol"},{"issue":"4","key":"10.1016\/j.bcp.2024.116273_b0060","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1002\/jor.22535","article-title":"Down-regulation of collagen synthesis and matrix metalloproteinase expression in myofibroblasts from dupuytren nodule using adenovirus-mediated relaxin gene therapy","volume":"32","author":"Kang","year":"2014","journal-title":"J. Orthop. Res."},{"issue":"3","key":"10.1016\/j.bcp.2024.116273_b0065","doi-asserted-by":"crossref","first-page":"e23","DOI":"10.1016\/j.jse.2010.11.024","article-title":"Glenoid fracture during manipulation under anesthesia for adhesive capsulitis: a case report","volume":"20","author":"Magnussen","year":"2011","journal-title":"J. Shoulder Elbow Surg."},{"issue":"1","key":"10.1016\/j.bcp.2024.116273_b0070","first-page":"172","article-title":"Brachial plexus palsy after manipulation of the shoulder","volume":"73","author":"Birch","year":"1991","journal-title":"The Journal of Bone & Joint Surgery British"},{"issue":"2","key":"10.1016\/j.bcp.2024.116273_b0075","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1242\/dmm.012062","article-title":"Diverse functions of matrix metalloproteinases during fibrosis","volume":"7","author":"Giannandrea","year":"2014","journal-title":"Dis. Model. Mech."},{"issue":"3","key":"10.1016\/j.bcp.2024.116273_b0080","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1172\/JCI0215518","article-title":"Evidence that fibroblasts derive from epithelium during tissue fibrosis","volume":"110","author":"Iwano","year":"2002","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.bcp.2024.116273_b0085","doi-asserted-by":"crossref","unstructured":"Kim, K.K., et al., Alveolar epithelial cell mesenchymal transition develops in vivo during pulmonary fibrosis and is regulated by the extracellular matrix. Proceedings of the National Academy of Sciences, 2006. 103(35): p. 13180-13185.","DOI":"10.1073\/pnas.0605669103"},{"issue":"10","key":"10.1016\/j.bcp.2024.116273_b0090","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1111\/bph.13529","article-title":"Anti-fibrotic actions of relaxin","volume":"174","author":"Samuel","year":"2017","journal-title":"Br. J. Pharmacol."},{"issue":"1","key":"10.1016\/j.bcp.2024.116273_b0095","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1210\/jcem-15-1-22","article-title":"The concentration of relaxin in the blood serum and other tissues of women during pregnancy","volume":"15","author":"Zarrow","year":"1955","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"8","key":"10.1016\/j.bcp.2024.116273_b0100","doi-asserted-by":"crossref","first-page":"661","DOI":"10.3181\/00379727-23-3107","article-title":"Experimental relaxation of the pubic ligament of the guinea pig","volume":"23","author":"Hisaw","year":"1926","journal-title":"Proc. Soc. Exp. Biol. Med."},{"issue":"6","key":"10.1016\/j.bcp.2024.116273_b0105","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1016\/0002-9343(56)90221-2","article-title":"Effects of relaxin in treatment of scleroderma","volume":"20","author":"Casten","year":"1956","journal-title":"Am. J. Med."},{"issue":"3","key":"10.1016\/j.bcp.2024.116273_b0110","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1111\/1523-1747.ep12365206","article-title":"Human relaxin decreases collagen accumulation in vivo in two rodent models of fibrosis","volume":"101","author":"Unemori","year":"1993","journal-title":"J, Invest. Dermatol."},{"issue":"1","key":"10.1016\/j.bcp.2024.116273_b0115","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1196\/annals.1282.025","article-title":"The relaxin gene-knockout mouse: a model of progressive fibrosis","volume":"1041","author":"Samuel","year":"2005","journal-title":"Ann. N. Y. Acad. Sci."},{"issue":"12","key":"10.1016\/j.bcp.2024.116273_b0120","doi-asserted-by":"crossref","first-page":"2739","DOI":"10.1172\/JCI119099","article-title":"Relaxin induces an extracellular matrix-degrading phenotype in human lung fibroblasts in vitro and inhibits lung fibrosis in a murine model in vivo","volume":"98","author":"Unemori","year":"1996","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.bcp.2024.116273_b0125","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.biochi.2021.06.001","article-title":"Relaxin in hepatic fibrosis: What is known and where to head?","volume":"187","author":"Ezhilarasan","year":"2021","journal-title":"Biochimie"},{"key":"10.1016\/j.bcp.2024.116273_b0130","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1016\/j.rmed.2016.08.022","article-title":"Anti-fibrotic effects of soluble guanylate cyclase stimulators and activators: A review of the preclinical evidence","volume":"122","author":"Sandner","year":"2017","journal-title":"Respir. Med."},{"issue":"2","key":"10.1016\/j.bcp.2024.116273_b0140","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1161\/HYPERTENSIONAHA.114.03594","article-title":"Serelaxin is a more efficacious antifibrotic than enalapril in an experimental model of heart disease","volume":"64","author":"Samuel","year":"2014","journal-title":"Hypertension"},{"issue":"5","key":"10.1016\/j.bcp.2024.116273_b0145","doi-asserted-by":"crossref","first-page":"e63896","DOI":"10.1371\/journal.pone.0063896","article-title":"Relaxin prevents cardiac fibroblast-myofibroblast transition via notch-1-mediated inhibition of TGF-\u03b2\/Smad3 signaling","volume":"8","author":"Sassoli","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.bcp.2024.116273_b0150","doi-asserted-by":"crossref","unstructured":"Chow, B.S.M., et al., Relaxin signals through a RXFP1-pERK-nNOS-NO-cGMP-dependent pathway to up-regulate matrix metalloproteinases: the additional involvement of iNOS. 2012.","DOI":"10.1371\/journal.pone.0042714"},{"issue":"9860","key":"10.1016\/j.bcp.2024.116273_b0155","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/S0140-6736(12)61855-8","article-title":"Serelaxin, recombinant human relaxin-2, for treatment of acute heart failure (RELAX-AHF): a randomised, placebo-controlled trial","volume":"381","author":"Teerlink","year":"2013","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.bcp.2024.116273_b0160","doi-asserted-by":"crossref","first-page":"2968","DOI":"10.1038\/s41598-017-02916-5","article-title":"ML290 is a biased allosteric agonist at the relaxin receptor RXFP1","volume":"7","author":"Kocan","year":"2017","journal-title":"Sci Rep"},{"issue":"11","key":"10.1016\/j.bcp.2024.116273_b0165","doi-asserted-by":"crossref","first-page":"12435","DOI":"10.1096\/fj.201901046R","article-title":"Therapeutic effects of a small molecule agonist of the relaxin receptor ML290 in liver fibrosis","volume":"33","author":"Kaftanovskaya","year":"2019","journal-title":"FASEB J"},{"issue":"8","key":"10.1016\/j.bcp.2024.116273_b0170","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1056\/NEJMoa1801291","article-title":"Effects of serelaxin in patients with acute heart failure","volume":"381","author":"Metra","year":"2019","journal-title":"N. Engl. J. Med."},{"issue":"10258","key":"10.1016\/j.bcp.2024.116273_b0175","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1016\/S0140-6736(20)30925-9","article-title":"Global burden of 369 diseases and injuries in 204 countries and territories, 1990\u20132019: a systematic analysis for the Global Burden of Disease Study 2019","volume":"396","author":"Vos","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.bcp.2024.116273_b0180","series-title":"IHME","author":"Compare","year":"2015"},{"issue":"4","key":"10.1016\/j.bcp.2024.116273_b0185","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1001\/jama.1958.02990040005002","article-title":"Use of relaxin in the treatment of scleroderma","volume":"166","author":"Casten","year":"1958","journal-title":"J Am Med Assoc"},{"issue":"2","key":"10.1016\/j.bcp.2024.116273_b0190","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1001\/archderm.1959.01560140012003","article-title":"Relaxin (releasin) therapy in diffuse progressive scleroderma; a preliminary report","volume":"79","author":"Evans","year":"1959","journal-title":"AMA Arch Derm"},{"issue":"11","key":"10.1016\/j.bcp.2024.116273_b0195","doi-asserted-by":"crossref","first-page":"871","DOI":"10.7326\/0003-4819-132-11-200006060-00004","article-title":"Recombinant human relaxin in the treatment of scleroderma. A randomized, double-blind, placebo-controlled trial","volume":"132","author":"Seibold","year":"2000","journal-title":"Ann Intern Med"},{"issue":"9","key":"10.1016\/j.bcp.2024.116273_b0200","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1093\/rheumatology\/kep202","article-title":"Sensitivity to change of the modified Rodnan skin score in diffuse systemic sclerosis\u2013assessment of individual body sites in two large randomized controlled trials","volume":"48","author":"Kaldas","year":"2009","journal-title":"Rheumatology (Oxford)"},{"issue":"18","key":"10.1016\/j.bcp.2024.116273_b0205","doi-asserted-by":"crossref","first-page":"10681","DOI":"10.1016\/S0021-9258(18)87000-4","article-title":"Relaxin modulates synthesis and secretion of procollagenase and collagen by human dermal fibroblasts","volume":"265","author":"Unemori","year":"1990","journal-title":"J Biol Chem"},{"issue":"3","key":"10.1016\/j.bcp.2024.116273_b0210","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1111\/1523-1747.ep12616665","article-title":"Relaxin alone and in conjunction with interferon-gamma decreases collagen synthesis by cultured human scleroderma fibroblasts","volume":"99","author":"Unemori","year":"1992","journal-title":"J Invest Dermatol"},{"issue":"3","key":"10.1016\/j.bcp.2024.116273_b0215","doi-asserted-by":"crossref","first-page":"407e","DOI":"10.1097\/PRS.0b013e31825dbf56","article-title":"Relaxin-expressing adenovirus decreases collagen synthesis and up-regulates matrix metalloproteinase expression in keloid fibroblasts: in vitro experiments","volume":"130","author":"Lee","year":"2012","journal-title":"Plast Reconstr Surg"},{"issue":"4","key":"10.1016\/j.bcp.2024.116273_b0220","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1111\/j.0022-202X.2005.23880.x","article-title":"The relaxin gene knockout mouse: a model of progressive scleroderma","volume":"125","author":"Samuel","year":"2005","journal-title":"J Invest Dermatol"},{"issue":"3","key":"10.1016\/j.bcp.2024.116273_b0225","doi-asserted-by":"crossref","first-page":"406","DOI":"10.56499\/jppres21.1317_10.3.406","article-title":"Effects of swimming exercise and RLN2 induction on relaxin levels, MMP-13, TGF\u03b2 expression in the pubic cartilage of pregnant rats","volume":"10","author":"Oktaviani","year":"2022","journal-title":"Journal of Pharmacy & Pharmacognosy Research"},{"issue":"11","key":"10.1016\/j.bcp.2024.116273_b0230","first-page":"2164","article-title":"Serum relaxin in systemic sclerosis","volume":"32","author":"Giordano","year":"2005","journal-title":"J Rheumatol"},{"issue":"4","key":"10.1016\/j.bcp.2024.116273_b0235","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1016\/S0030-5898(02)00028-7","article-title":"The female ACL: why is it more prone to injury?","volume":"33","author":"Ireland","year":"2002","journal-title":"Orthop Clin North Am"},{"issue":"4","key":"10.1016\/j.bcp.2024.116273_b0240","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1177\/03635465030310041701","article-title":"Relaxin receptors in the human female anterior cruciate ligament","volume":"31","author":"Dragoo","year":"2003","journal-title":"Am J Sports Med"},{"issue":"10","key":"10.1016\/j.bcp.2024.116273_b0245","doi-asserted-by":"crossref","first-page":"2175","DOI":"10.1177\/0363546511413378","article-title":"Prospective correlation between serum relaxin concentration and anterior cruciate ligament tears among elite collegiate female athletes","volume":"39","author":"Dragoo","year":"2011","journal-title":"Am J Sports Med"},{"issue":"1","key":"10.1016\/j.bcp.2024.116273_b0250","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.knee.2008.09.005","article-title":"The effect of relaxin on the female anterior cruciate ligament: Analysis of mechanical properties in an animal model","volume":"16","author":"Dragoo","year":"2009","journal-title":"Knee"},{"issue":"9","key":"10.1016\/j.bcp.2024.116273_b0255","doi-asserted-by":"crossref","first-page":"2384","DOI":"10.1177\/0363546516646374","article-title":"The Intracellular Effect of Relaxin on Female Anterior Cruciate Ligament Cells","volume":"44","author":"Konopka","year":"2016","journal-title":"Am J Sports Med"},{"issue":"7","key":"10.1016\/j.bcp.2024.116273_b0260","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1290\/0512089.1","article-title":"Quantitation of estrogen receptors and relaxin binding in human anterior cruciate ligament fibroblasts","volume":"42","author":"Faryniarz","year":"2006","journal-title":"In Vitro Cell Dev Biol Anim"},{"issue":"5","key":"10.1016\/j.bcp.2024.116273_b0265","doi-asserted-by":"crossref","first-page":"385","DOI":"10.2106\/JBJS.K.00919","article-title":"Molecular analysis of age and sex-related gene expression in meniscal tears with and without a concomitant anterior cruciate ligament tear","volume":"94","author":"Brophy","year":"2012","journal-title":"J Bone Joint Surg Am"},{"key":"10.1016\/j.bcp.2024.116273_b0270","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1097\/00003086-200003000-00011","article-title":"Upper extremity disorders in women","volume":"372","author":"Newport","year":"2000","journal-title":"Clin Orthop Relat Res"},{"issue":"4","key":"10.1016\/j.bcp.2024.116273_b0275","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1007\/s11999-013-2960-4","article-title":"Relationship of relaxin hormone and thumb carpometacarpal joint arthritis","volume":"472","author":"Wolf","year":"2014","journal-title":"Clin Orthop Relat Res"},{"issue":"4","key":"10.1016\/j.bcp.2024.116273_b0280","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1016\/j.jhsa.2013.01.019","article-title":"Relationship of serum relaxin to generalized and trapezial-metacarpal joint laxity","volume":"38","author":"Wolf","year":"2013","journal-title":"J Hand Surg Am"},{"issue":"1","key":"10.1016\/j.bcp.2024.116273_b0285","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.jhsa.2005.09.012","article-title":"Immunohistochemical detection of relaxin binding to the volar oblique ligament","volume":"31","author":"Lubahn","year":"2006","journal-title":"J Hand Surg Am"},{"issue":"8","key":"10.1016\/j.bcp.2024.116273_b0290","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1002\/jor.22640","article-title":"Detection of relaxin receptor in the dorsoradial ligament, synovium, and articular cartilage of the trapeziometacarpal joint","volume":"32","author":"Clifton","year":"2014","journal-title":"J Orthop Res"},{"issue":"2","key":"10.1016\/j.bcp.2024.116273_b0295","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1016\/S0002-9378(96)70447-7","article-title":"Peripheral joint laxity increases in pregnancy but does not correlate with serum relaxin levels","volume":"174","author":"Schauberger","year":"1996","journal-title":"Am. J. Obstet. Gynecol."},{"issue":"2","key":"10.1016\/j.bcp.2024.116273_b0300","first-page":"331","article-title":"Characterization of the relationship between joint laxity and maternal hormones in pregnancy","volume":"101","author":"Marnach","year":"2003","journal-title":"Obstet. Gynecol."},{"issue":"2","key":"10.1016\/j.bcp.2024.116273_b0305","doi-asserted-by":"crossref","first-page":"180","DOI":"10.7150\/ijms.6283","article-title":"Sex-steroid regulation of relaxin receptor isoforms (RXFP1 & RXFP2) expression in the patellar tendon and lateral collateral ligament of female WKY rats","volume":"11","author":"Dehghan","year":"2014","journal-title":"Int J Med Sci"},{"issue":"1","key":"10.1016\/j.bcp.2024.116273_b0310","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1186\/s12891-019-2729-3","article-title":"Relaxin inhibits patellar tendon healing in rats: a histological and biochemical evaluation","volume":"20","author":"Xu","year":"2019","journal-title":"BMC Musculoskelet Disord"},{"key":"10.1016\/j.bcp.2024.116273_b0315","first-page":"75","article-title":"Tendon creep is potentiated by NKISK and relaxin which produce collagen fiber sliding","volume":"23","author":"Wood","year":"2003","journal-title":"Iowa Orthop J"},{"issue":"7","key":"10.1016\/j.bcp.2024.116273_b0320","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1113\/expphysiol.2011.057877","article-title":"Serum relaxin levels affect the in vivo properties of some but not all tendons in normally menstruating young women","volume":"96","author":"Pearson","year":"2011","journal-title":"Exp Physiol"},{"issue":"2","key":"10.1016\/j.bcp.2024.116273_b0325","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/S0005-2728(88)80081-1","article-title":"Effect of relaxin on the phenotype of collagens synthesized by cultured rabbit chondrocytes","volume":"972","author":"Bonaventure","year":"1988","journal-title":"Biochim Biophys Acta"},{"issue":"8","key":"10.1016\/j.bcp.2024.116273_b0330","first-page":"925","article-title":"Targeted induction of collagenase and stromelysin by relaxin in unprimed and beta-estradiol-primed diarthrodial joint fibrocartilaginous cells but not in synoviocytes","volume":"78","author":"Kapila","year":"1998","journal-title":"Lab Invest"},{"issue":"1","key":"10.1016\/j.bcp.2024.116273_b0335","doi-asserted-by":"crossref","first-page":"R1","DOI":"10.1186\/ar1451","article-title":"Relaxin's induction of metalloproteinases is associated with the loss of collagen and glycosaminoglycans in synovial joint fibrocartilaginous explants","volume":"7","author":"Naqvi","year":"2005","journal-title":"Arthritis Res Ther"},{"issue":"9","key":"10.1016\/j.bcp.2024.116273_b0340","doi-asserted-by":"crossref","first-page":"3884","DOI":"10.1210\/endo.137.9.8756561","article-title":"The effect of relaxin on collagen metabolism in the nonpregnant rat pubic symphysis: the influence of estrogen and progesterone in regulating relaxin activity","volume":"137","author":"Samuel","year":"1996","journal-title":"Endocrinology"},{"issue":"1","key":"10.1016\/j.bcp.2024.116273_b0345","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1186\/s12891-022-05677-z","article-title":"Management of arthrofibrosis in neuromuscular disorders: a review","volume":"23","author":"Martinez-Lozano","year":"2022","journal-title":"BMC Musculoskelet. Disord."},{"issue":"1","key":"10.1016\/j.bcp.2024.116273_b0350","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1177\/1758573218793903","article-title":"Post-traumatic elbow stiffness: Pathogenesis and current treatments","volume":"12","author":"Zhang","year":"2020","journal-title":"Should. Elb."},{"issue":"2","key":"10.1016\/j.bcp.2024.116273_b0355","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1177\/1758573216676786","article-title":"Adhesive capsulitis of the shoulder: review of pathophysiology and current clinical treatments","volume":"9","author":"Le","year":"2017","journal-title":"Should. Elb."},{"issue":"1","key":"10.1016\/j.bcp.2024.116273_b0360","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1038\/s41413-019-0047-x","article-title":"Pathological mechanisms and therapeutic outlooks for arthrofibrosis","volume":"7","author":"Usher","year":"2019","journal-title":"Bone Res."},{"issue":"7","key":"10.1016\/j.bcp.2024.116273_b0365","doi-asserted-by":"crossref","first-page":"e19","DOI":"10.2106\/JBJS.RVW.19.00223","article-title":"Clinical management of arthrofibrosis: state of the art and therapeutic outlook","volume":"8","author":"Ibrahim","year":"2020","journal-title":"JBJS Reviews"},{"issue":"2","key":"10.1016\/j.bcp.2024.116273_b0370","doi-asserted-by":"crossref","first-page":"221","DOI":"10.3109\/2000-1967-223","article-title":"Expression of transforming growth factor-\u03b21 and connective tissue growth factor in the capsule in a rat immobilized knee model","volume":"113","author":"Hagiwara","year":"2008","journal-title":"Ups. J. Med. Sci."},{"issue":"11","key":"10.1016\/j.bcp.2024.116273_b0375","doi-asserted-by":"crossref","first-page":"2549","DOI":"10.1016\/j.humpath.2013.06.016","article-title":"Fibroblast activation protein expression by stromal cells and tumor-associated macrophages in human breast cancer","volume":"44","author":"Tchou","year":"2013","journal-title":"Hum Pathol"},{"issue":"4","key":"10.1016\/j.bcp.2024.116273_b0380","doi-asserted-by":"crossref","first-page":"e0215301","DOI":"10.1371\/journal.pone.0215301","article-title":"Fibroblast activation and inflammation in frozen shoulder","volume":"14","author":"Akbar","year":"2019","journal-title":"PLoS One"},{"issue":"25","key":"10.1016\/j.bcp.2024.116273_b0385","doi-asserted-by":"crossref","first-page":"12183","DOI":"10.1073\/pnas.1900355116","article-title":"Intraarticular injection of relaxin-2 alleviates shoulder arthrofibrosis","volume":"116","author":"Blessing","year":"2019","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.bcp.2024.116273_b0390","doi-asserted-by":"crossref","unstructured":"Kirsch, J.R., et al., Minimally invasive, sustained-release relaxin-2 microparticles reverse arthrofibrosis. Science translational medicine, 2022. 14(666): p. eabo3357.","DOI":"10.1126\/scitranslmed.abo3357"},{"issue":"3","key":"10.1016\/j.bcp.2024.116273_b0395","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1016\/S0002-9440(10)63188-4","article-title":"Transforming growth factor-beta1 induces the differentiation of myogenic cells into fibrotic cells in injured skeletal muscle: a key event in muscle fibrogenesis","volume":"164","author":"Li","year":"2004","journal-title":"Am J Pathol"},{"issue":"12","key":"10.1016\/j.bcp.2024.116273_b0400","doi-asserted-by":"crossref","first-page":"1816","DOI":"10.1177\/0363546505278701","article-title":"The effect of relaxin treatment on skeletal muscle injuries","volume":"33","author":"Negishi","year":"2005","journal-title":"Am J Sports Med"},{"issue":"5","key":"10.1016\/j.bcp.2024.116273_b0405","doi-asserted-by":"crossref","first-page":"2399","DOI":"10.2353\/ajpath.2010.091121","article-title":"Relaxin regulates MMP expression and promotes satellite cell mobilization during muscle healing in both young and aged mice","volume":"177","author":"Mu","year":"2010","journal-title":"Am J Pathol"},{"issue":"10","key":"10.1016\/j.bcp.2024.116273_b0410","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1111\/bph.13523","article-title":"The actions of relaxin on the human cardiovascular system","volume":"174","author":"Sarwar","year":"2017","journal-title":"Br J Pharmacol"},{"issue":"9","key":"10.1016\/j.bcp.2024.116273_b0415","doi-asserted-by":"crossref","first-page":"774","DOI":"10.3390\/antiox9090774","article-title":"Human Relaxin-2 (Serelaxin) Attenuates Oxidative Stress in Cardiac Muscle Cells Exposed In Vitro to Hypoxia-Reoxygenation. Evidence for the Involvement of Reduced Glutathione Up-Regulation","volume":"9","author":"Nistri","year":"2020","journal-title":"Antioxidants"},{"issue":"3","key":"10.1016\/j.bcp.2024.116273_b0420","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1016\/j.cardiores.2004.03.027","article-title":"Gender modulates cardiac phenotype development in genetically modified mice","volume":"63","author":"Du","year":"2004","journal-title":"Cardiovasc Res"},{"issue":"2","key":"10.1016\/j.bcp.2024.116273_b0425","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1016\/j.pharmthera.2005.10.016","article-title":"Sex dimorphism in cardiac pathophysiology: experimental findings, hormonal mechanisms, and molecular mechanisms","volume":"111","author":"Du","year":"2006","journal-title":"Pharmacol Ther"},{"key":"10.1016\/j.bcp.2024.116273_b0430","doi-asserted-by":"crossref","unstructured":"Dubey, R.K. and E.K. Jackson, Cardiovascular protective effects of 17beta-estradiol metabolites. J Appl Physiol (1985), 2001. 91(4): p. 1868-83.","DOI":"10.1152\/jappl.2001.91.4.1868"},{"issue":"2","key":"10.1016\/j.bcp.2024.116273_b0435","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1016\/j.bbrc.2003.09.232","article-title":"17 beta-estradiol inhibits cardiac fibroblast growth through both subtypes of estrogen receptor","volume":"311","author":"Watanabe","year":"2003","journal-title":"Biochem Biophys Res Commun"},{"issue":"1","key":"10.1016\/j.bcp.2024.116273_b0440","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1053\/jarr.2003.50001","article-title":"The role of gender in the progression of renal disease","volume":"10","author":"Silbiger","year":"2003","journal-title":"Adv Ren Replace Ther"},{"issue":"6","key":"10.1016\/j.bcp.2024.116273_b0445","first-page":"F875","article-title":"Estradiol suppresses mesangial cell type I collagen synthesis via activation of the MAP kinase cascade","volume":"277","author":"Neugarten","year":"1999","journal-title":"Am J Physiol"},{"issue":"4","key":"10.1016\/j.bcp.2024.116273_b0450","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1002\/jor.1100140405","article-title":"Primary immunolocalization of estrogen and progesterone target cells in the human anterior cruciate ligament","volume":"14","author":"Liu","year":"1996","journal-title":"J Orthop Res"},{"issue":"8","key":"10.1016\/j.bcp.2024.116273_b0455","doi-asserted-by":"crossref","first-page":"e0160984","DOI":"10.1371\/journal.pone.0160984","article-title":"Changes in knee laxity and relaxin receptor isoforms expression (RXFP1\/RXFP2) in the knee throughout estrous cycle phases in rodents","volume":"11","author":"Dehghan","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.bcp.2024.116273_b0460","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1097\/00003086-199909000-00030","article-title":"Effect of estrogen on cellular metabolism of the human anterior cruciate ligament","volume":"366","author":"Yu","year":"1999","journal-title":"Clin Orthop Relat Res"},{"issue":"4","key":"10.1016\/j.bcp.2024.116273_b0465","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1007\/s00167-006-0237-0","article-title":"Reproductive hormone effects on strength of the rat anterior cruciate ligament","volume":"15","author":"Woodhouse","year":"2007","journal-title":"Knee Surg Sports Traumatol Arthrosc"},{"key":"10.1016\/j.bcp.2024.116273_b0470","doi-asserted-by":"crossref","unstructured":"Herzberg, S.D., et al., The Effect of Menstrual Cycle and Contraceptives on ACL Injuries and Laxity: A Systematic Review and Meta-analysis. Orthop J Sports Med, 2017. 5(7): p. 2325967117718781.","DOI":"10.1177\/2325967117718781"},{"issue":"1","key":"10.1016\/j.bcp.2024.116273_b0475","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1210\/en.2011-1311","article-title":"Relaxin and castration in male mice protect from, but testosterone exacerbates, age-related cardiac and renal fibrosis, whereas estrogens are an independent determinant of organ size","volume":"153","author":"Hewitson","year":"2012","journal-title":"Endocrinology"},{"issue":"12","key":"10.1016\/j.bcp.2024.116273_b0480","doi-asserted-by":"crossref","first-page":"5575","DOI":"10.1210\/en.2006-0533","article-title":"The effects of relaxin and estrogen deficiency on collagen deposition and hypertrophy of nonreproductive organs","volume":"147","author":"Lekgabe","year":"2006","journal-title":"Endocrinology"},{"issue":"4","key":"10.1016\/j.bcp.2024.116273_b0485","doi-asserted-by":"crossref","first-page":"1868","DOI":"10.1152\/jappl.2001.91.4.1868","article-title":"Invited review: cardiovascular protective effects of 17\u03b2-estradiol metabolites","volume":"91","author":"Dubey","year":"2001","journal-title":"J. Appl. Physiol."},{"issue":"2","key":"10.1016\/j.bcp.2024.116273_b0490","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1016\/j.bbrc.2003.09.232","article-title":"17\u03b2-Estradiol inhibits cardiac fibroblast growth through both subtypes of estrogen receptor","volume":"311","author":"Watanabe","year":"2003","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.bcp.2024.116273_b0495","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1097\/00003086-199909000-00030","article-title":"Effect of estrogen on cellular metabolism of the human anterior cruciate ligament","volume":"366","author":"Warren","year":"1999","journal-title":"Clinical Orthopaedics and Related Research\u00ae"},{"key":"10.1016\/j.bcp.2024.116273_b0500","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1007\/s00167-006-0237-0","article-title":"Reproductive hormone effects on strength of the rat anterior cruciate ligament","volume":"15","author":"Woodhouse","year":"2007","journal-title":"Knee Surg. Sports Traumatol. Arthrosc."},{"issue":"19","key":"10.1016\/j.bcp.2024.116273_b0505","doi-asserted-by":"crossref","first-page":"14747","DOI":"10.1074\/jbc.M109.093039","article-title":"Estrogen inhibits transforming growth factor \u03b2 signaling by promoting Smad2\/3 degradation","volume":"285","author":"Ito","year":"2010","journal-title":"J. Biol. Chem."},{"issue":"3","key":"10.1016\/j.bcp.2024.116273_b0510","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1006\/bbrc.2001.4827","article-title":"Nongenomic estrogen action in human lung myofibroblasts","volume":"283","author":"Flores-Delgado","year":"2001","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.bcp.2024.116273_b0515","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1111\/j.1749-6632.2009.03830.x","article-title":"Matrix metalloproteinase induction by relaxin causes cartilage matrix degradation in target synovial joints","volume":"1160","author":"Kapila","year":"2009","journal-title":"Ann N Y Acad Sci"},{"issue":"8","key":"10.1016\/j.bcp.2024.116273_b0520","doi-asserted-by":"crossref","first-page":"3319","DOI":"10.1007\/s00590-023-03618-7","article-title":"The role of relaxin in anterior cruciate ligament injuries: a systematic review","volume":"33","author":"Berger","year":"2023","journal-title":"Eur. J. Orthop. Surg. Traumatol."},{"issue":"1\u20132","key":"10.1016\/j.bcp.2024.116273_b0525","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/0303-7207(93)90025-F","article-title":"Sequential appearance of relaxin, prolactin and IGFBP-1 during growth and differentiation of the human endometrium","volume":"95","author":"Bryant-Greenwood","year":"1993","journal-title":"Mol. Cell. Endocrinol."},{"issue":"4","key":"10.1016\/j.bcp.2024.116273_b0530","doi-asserted-by":"crossref","first-page":"e724","DOI":"10.3928\/01477447-20160421-01","article-title":"Association between serum relaxin and subsequent shoulder instability","volume":"39","author":"Owens","year":"2016","journal-title":"Orthopedics"},{"key":"10.1016\/j.bcp.2024.116273_b0535","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1007\/s11999-013-2960-4","article-title":"Relationship of relaxin hormone and thumb carpometacarpal joint arthritis","volume":"472","author":"Wolf","year":"2014","journal-title":"Clinical Orthopaedics and Related Research\u00ae"},{"key":"10.1016\/j.bcp.2024.116273_b0540","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1023\/A:1018901009062","article-title":"The pharmacokinetics of recombinant human relaxin in nonpregnant women after intravenous, intravaginal, and intracervical administration","volume":"10","author":"Chen","year":"1993","journal-title":"Pharm. Res."},{"issue":"11","key":"10.1016\/j.bcp.2024.116273_b0545","doi-asserted-by":"crossref","first-page":"871","DOI":"10.7326\/0003-4819-132-11-200006060-00004","article-title":"Recombinant human relaxin in the treatment of scleroderma: a randomized, double-blind, placebo-controlled trial","volume":"132","author":"Seibold","year":"2000","journal-title":"Ann. Intern. Med."},{"issue":"4","key":"10.1016\/j.bcp.2024.116273_b0550","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1002\/art.24380","article-title":"A randomized, double-blind, placebo-controlled trial of recombinant human relaxin in the treatment of systemic sclerosis with diffuse scleroderma","volume":"60","author":"Khanna","year":"2009","journal-title":"Arthritis Rheum."},{"issue":"4","key":"10.1016\/j.bcp.2024.116273_b0555","doi-asserted-by":"crossref","first-page":"2139","DOI":"10.1021\/acs.jmedchem.0c01533","article-title":"Identification of potent and long-acting single-chain peptide mimetics of human relaxin-2 for cardiovascular diseases","volume":"64","author":"Mallart","year":"2021","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bcp.2024.116273_b0560","doi-asserted-by":"crossref","unstructured":"Rosenmeier, J., et al., Safety, tolerability, and pharmacokinetics of AZD5462, a small molecule agonist of the RXFP1 relaxin receptor. European Heart Journal, 2023. 44(Supplement_2): p. ehad655. 976.","DOI":"10.1093\/eurheartj\/ehad655.976"},{"issue":"1","key":"10.1016\/j.bcp.2024.116273_b0565","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1038\/s42003-022-04143-9","article-title":"Discovery of small molecule agonists of the Relaxin Family Peptide Receptor 2","volume":"5","author":"Esteban-Lopez","year":"2022","journal-title":"Communications Biology"},{"issue":"11","key":"10.1016\/j.bcp.2024.116273_b0570","doi-asserted-by":"crossref","first-page":"2191","DOI":"10.1681\/ASN.2019060597","article-title":"AT1R-AT2R-RXFP1 functional crosstalk in myofibroblasts: impact on the therapeutic targeting of renal and cardiac fibrosis","volume":"30","author":"Chow","year":"2019","journal-title":"J Am Soc Nephrol"}],"container-title":["Biochemical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295224002569?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295224002569?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,19]],"date-time":"2024-06-19T23:38:51Z","timestamp":1718840331000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006295224002569"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7]]},"references-count":113,"alternative-id":["S0006295224002569"],"URL":"https:\/\/doi.org\/10.1016\/j.bcp.2024.116273","relation":{},"ISSN":["0006-2952"],"issn-type":[{"value":"0006-2952","type":"print"}],"subject":[],"published":{"date-parts":[[2024,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Relaxin as a treatment for musculoskeletal fibrosis: What we know and future directions","name":"articletitle","label":"Article Title"},{"value":"Biochemical Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bcp.2024.116273","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"116273"}}